$PL

Brennan Ita M sold $379K of PL

Brennan Ita M sold 11,500 shares of Planet Labs PBC (PL) at $33.00 ($0.38M total) on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Brennan Ita M
Published Jul 2, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:40 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PL
Neutral
medium confidence
Mentioned
$PL
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLNeutralLow
01

Why it matters

A director’s open-market sale of 11,500 shares is disclosed, with the key mitigating factor being that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may briefly reassess sentiment around insider activity, but the 10b5-1 framing makes this more of a monitoring datapoint than a catalyst.

03

What to watch

The article does not state whether the sale was part of a broader pattern, nor does it provide context on total holdings changes beyond the post-transaction share count.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-02, transaction dated 2026-07-01

Background

The article is an SEC Form 4 insider transaction disclosure for Planet Labs PBC.

Company-level read

Ticker impact

$PLNeutralMedium confidence
Context

Planet Labs PBC director Brennan Ita M sold 11,500 shares for about $379K under a pre-arranged 10b5-1 plan filed on SEC EDGAR.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived and sentiment-driven.

Evidence & confidence

The filing specifies an open-market sale and confirms a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still signal management’s view of near-term risk or liquidity needs, so traders may watch for follow-on sales.

Key entities

  • Planet Labs PBC

    US-listed company whose director insider sale is disclosed on SEC Form 4.

  • Brennan Ita M

    Director who sold 11,500 shares on 2026-07-01 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PLMed

Planet Labs PBC Q2 2027 Earnings Call Summary

Planet Labs PBC reported Q2 2027 revenue growth of 58% YoY, driven by Satellite Services and Defense sectors. Non-GAAP gross margins reached 59%. The company increased CapEx guidance to $100M-$115M for next-gen constellations and maintains $850M in cash. Management highlighted a $4B pipeline for Satellite Services and strategic expansion in Europe.

$PLHighAI 8/10

Planet Labs Shares Jump After Q2 Results Beat Expectations

Planet Labs (PL) reported Q2 2027 revenue of $116.1M, up 58% YoY, beating estimates. Adjusted EPS was $0.02, surpassing expectations. Defense and intelligence revenue rose 90% YoY. The company raised FY2027 revenue guidance to $430M-$441M. Shares rose 14.1% in pre-market trading.

$PLHighAI 8/10

Planet Labs Rallies 10% as Record Revenue Overrides Soft Q3 Guidance

Planet Labs (PL) stock rose 10% after reporting Q2 revenue of $116.1M, beating estimates by 11%, and adjusted EPS of $0.02, reversing a pre-earnings decline. Despite softer Q3 guidance, the company highlights a $4B sovereign satellite-services pipeline. Defense and intelligence revenue grew over 90% YoY, and non-GAAP gross margin was 59%.